Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4023153018 | Brexucabtagene autoleucel-containing product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4023154012 | Product containing brexucabtagene autoleucel (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing brexucabtagene autoleucel (medicinal product) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing brexucabtagene autoleucel (medicinal product) | Is a | Medicinal product acting as antineoplastic agent (product) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing brexucabtagene autoleucel (medicinal product) | Is a | Product containing genetically modified T-cell | true | Inferred relationship | Existential restriction modifier | ||
| Product containing brexucabtagene autoleucel (medicinal product) | Has active ingredient | Brexucabtagene autoleucel | true | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Brexucabtagene autoleucel | Is a | True | Product containing brexucabtagene autoleucel (medicinal product) | Inferred relationship | Existential restriction modifier | |
| Product containing brexucabtagene autoleucel in parenteral dose form (medicinal product form) | Is a | True | Product containing brexucabtagene autoleucel (medicinal product) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR